Search - tctmd.com

Displaying 281 - 300 of 420

Sort: Relevancy | Date

Presentation TCT 2015

What Are the Indications for TAVR in 2015? According to the EU and US Guidelines

Presenter: Martin B. Leon, Neil E. Moat, Alec S. Vahanian

October 11, 2015

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2015

Whats Controversial or Unsettled in the Guidelines?

Presenter: Patrick T. O'Gara, Allan Schwartz, Robert O. Bonow

October 11, 2015

Presentation TCT 2015

Whats New in the Guidelines?

Presenter: Patrick T. O'Gara, Allan Schwartz, Catherine M. Otto

October 11, 2015

News Conference News TCT 2015

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

October 11, 2015

News Conference News TCT 2015

Leadership at Forefront of Cath Lab Operations

Yael L. Maxwell

October 11, 2015

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

News Conference News TCT 2015

FFR Guidance Could Reduce Need for Multivessel Primary PCI

October 11, 2015

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

News Conference News TCT 2014

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Todd Neale

October 17, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

Presentation TCT 2014

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Kenya Brothers

September 16, 2014

Presentation TCT 2014

Approach to the Diagnosis and Treatment of Takotsubo Syndrome: The New ESC Consensus Document

Presenter: Christian W. Hamm, Patrick T. O'Gara, Peter L. Duffy, Elmir Omerovic

September 16, 2014

Presentation TCT 2014

Fundamentals of Left Main Intervention: Managing Guidelines/AUC, Cardiac Surgeons, and the Heart Team

Presenter: Jean Fajadet, Marie-Claude Morice, Margaret B. McEntegart, Nicholas J. Lembo

September 16, 2014

Presentation TCT 2014

Summary of Current US and EU Guidelines and AUC for Left Main Revascularization: Consistencies and Gaps

Presenter: Jean Fajadet, Marie-Claude Morice, Margaret B. McEntegart, Ajay J. Kirtane

September 16, 2014

Presentation TCT 2014

Con: The Guidelines are Appropriately Conservative!

Presenter: Adrian P. Banning, Nick Curzen

September 16, 2014

Presentation TCT 2014

Pro: The Guidelines are Antiquated!

Presenter: Adrian P. Banning, Cindy L. Grines

September 16, 2014

News Conference News TCT 2014

The Long Road to a Shorter Door-to-Balloon Time

September 16, 2014

Presentation TCT 2014

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Ted E. Feldman

September 15, 2014

Advertisement

What Are the Indications for TAVR in 2015? According to the EU and US Guidelines

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Whats Controversial or Unsettled in the Guidelines?

Whats New in the Guidelines?

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

Leadership at Forefront of Cath Lab Operations

Global TAVR Market Poised to Exceed DES Market by 2025

FFR Guidance Could Reduce Need for Multivessel Primary PCI

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Approach to the Diagnosis and Treatment of Takotsubo Syndrome: The New ESC Consensus Document

Fundamentals of Left Main Intervention: Managing Guidelines/AUC, Cardiac Surgeons, and the Heart Team

Summary of Current US and EU Guidelines and AUC for Left Main Revascularization: Consistencies and Gaps

Con: The Guidelines are Appropriately Conservative!

Pro: The Guidelines are Antiquated!

The Long Road to a Shorter Door-to-Balloon Time

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content